EBS · Emergent BioSolutions Inc. · Documents
$6.20
-0.09 (-1.43%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$317.89M
Shares
51.27M
Volume · Oct 21
851.82K
Avg daily vol (3M)
1.19M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Emergent BioSolutions announced Richard Lindahl will retire as CFO effective December 31, 2026, transitioning to an advisor until March 31, 2027. Frank Vargo, currently VP, Treasurer, will serve as Interim CFO beginning January 1, 2027. | 2026-10-16 | — | |
| 8-K | — | 2026-09-14 | — | |
| Investor Event Transcript | — | 2026-09-14 | 2026-09-30 | |
| 8-K | — | 2026-09-01 | 2026-08-18 | |
| 10-Q | — | 2026-08-06 | 2026-06-30 | |
| 8-K | — | 2026-08-05 | — | |
| 8-K | — | 2026-06-29 | 2026-06-26 | |
| 10-Q | — | 2026-05-01 | 2026-03-31 | |
| 8-K | — | 2026-04-30 | — | |
| 8-K | — | 2026-04-30 | 2026-04-29 | |
| DEFA14A | — | 2026-04-28 | — | |
| DEFA14A | — | 2026-04-27 | — | |
| DEFA14A | — | 2026-04-22 | — | |
| 8-K | — | 2026-04-17 | 2026-04-16 | |
| DEFA14A | — | 2026-04-16 | — | |
| DEFA14A | — | 2026-04-16 | — | |
| DEF 14A | — | 2026-03-20 | 2025-12-31 | |
| ARS | — | 2026-03-20 | 2025-12-31 | |
| DEFA14A | — | 2026-03-20 | — | |
| 8-K | — | 2026-03-03 | 2026-02-25 | |
| 10-K | — | 2026-02-27 | 2025-12-31 | |
| 8-K | — | 2026-02-26 | — | |
| 8-K | — | 2026-01-14 | — | |
| 8-K | — | 2026-01-12 | — | |
| 8-K | — | 2025-12-12 | — | |
| 8-K | — | 2025-11-12 | 2025-11-07 | |
| 10-Q | — | 2025-10-30 | 2025-09-30 | |
| 8-K | — | 2025-10-29 | — | |
| 8-K | — | 2025-09-11 | 2025-09-05 | |
| 8-K | — | 2025-09-05 | 2025-09-02 | |
| S-3 | — | 2025-08-07 | — | |
| 10-Q | — | 2025-08-07 | 2025-06-30 | |
| 8-K | — | 2025-08-06 | — | |
| 8-K | — | 2025-06-24 | 2025-06-23 | |
| 8-K | — | 2025-05-23 | — | |
| 10-Q | — | 2025-05-08 | 2025-03-31 | |
| 8-K | — | 2025-05-07 | — | |
| 8-K | — | 2025-05-06 | 2025-04-30 | |
| 8-K | — | 2025-03-31 | — | |
| 8-K | — | 2025-03-24 | 2025-03-19 | |
| DEFA14A | — | 2025-03-21 | — | |
| ARS | — | 2025-03-21 | 2024-12-31 | |
| DEF 14A | — | 2025-03-21 | 2024-12-31 | |
| 8-K | — | 2025-03-10 | — | |
| 10-K | — | 2025-03-04 | 2024-12-31 | |
| 8-K | — | 2025-03-03 | — | |
| 8-K | — | 2025-01-15 | — | |
| 8-K | — | 2025-01-14 | — | |
| 8-K | — | 2025-01-08 | 2024-12-12 | |
| S-1/A | — | 2024-12-02 | — |
Showing 1–50 of 192 filings
Key facts
CIK
1367644
CUSIP
29089Q105
13F (30d)
22 filings
22 filers
Visit website
Investor relations